BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29058598)

  • 21. Validity of self-reported cancer history in the health examinees (HEXA) study: A comparison of self-report and cancer registry records.
    Cho S; Shin A; Song D; Park JK; Kim Y; Choi JY; Kang D; Lee JK
    Cancer Epidemiol; 2017 Oct; 50(Pt A):16-21. PubMed ID: 28763723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
    Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
    Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of self-reported breast cancer among women undergoing mammography.
    Abraham L; Geller BM; Yankaskas BC; Bowles EJ; Karliner LS; Taplin SH; Miglioretti DL
    Breast Cancer Res Treat; 2009 Dec; 118(3):583-92. PubMed ID: 19301119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.
    Puig-Vives M; Sánchez MJ; Sánchez-Cantalejo J; Torrella-Ramos A; Martos C; Ardanaz E; Chirlaque MD; Perucha J; Díaz JM; Mateos A; Machón M; Marcos-Gragera R
    Gynecol Oncol; 2013 Sep; 130(3):609-14. PubMed ID: 23747837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.
    Silva A; Rauscher GH; Ferrans CE; Hoskins K; Rao R
    J Registry Manag; 2014; 41(1):24-30. PubMed ID: 24893185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study.
    Colditz GA; Willett WC; Hunter DJ; Stampfer MJ; Manson JE; Hennekens CH; Rosner BA
    JAMA; 1993 Jul; 270(3):338-43. PubMed ID: 8123079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of self-reported family history of cancer: A systematic literature review on selected cancers.
    Fiederling J; Shams AZ; Haug U
    Int J Cancer; 2016 Oct; 139(7):1449-60. PubMed ID: 27222437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer.
    Osborne C; Ostir GV; Du X; Peek MK; Goodwin JS
    Breast Cancer Res Treat; 2005 Sep; 93(1):41-7. PubMed ID: 16184457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: the Women's Health Cohort Study.
    Karlson EW; Lee IM; Cook NR; Manson JE; Buring JE; Hennekens CH
    Am J Epidemiol; 1999 Sep; 150(6):652-60. PubMed ID: 10490005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assisted reproductive technology use and outcomes among women with a history of cancer.
    Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
    Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer.
    Ivanovich J; Babb S; Goodfellow P; Mutch D; Herzog T; Rader J; Whelan A
    Clin Cancer Res; 2002 Jun; 8(6):1849-56. PubMed ID: 12060627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
    Subramaniam S; Bhoo-Pathy N; Taib NA; Tan GH; See MH; Jamaris S; Ho GF; Looi LM; Yip CH
    World J Surg; 2015 Oct; 39(10):2450-8. PubMed ID: 26138872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
    Kool M; Bastiaannet E; Van de Velde CJH; Marang-van de Mheen PJ
    Clin Breast Cancer; 2018 Jun; 18(3):234-238. PubMed ID: 28888579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.